An analysis of Awanui Labs' financial losses and monopoly position reveals growing concerns about the sustainability of New Zealand's pathology services and the risks of overreliance on a single provider in the public health system.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
staff shortages and industrial action amid strain
An uncomfortable truth: NZ’s money-losing medical monopoly is too big to failSpotted something wrong on this page? Report a correction.